An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan

This publication has 15 references indexed in Scilit:

• Comparative Efficacy of Two Angiotensin II Receptor Antagonists, Irbesartan and Losartan, in Mild-to-Moderate Hypertension
  American Journal of Hypertension, 1998
• Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
  American Journal of Hypertension, 1998
• 24-Hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring
  Journal Of Hypertension, 1997
• E9 Dose-related reductions in blood pressure with irbesartan, the angiotensin II receptor antagonist
  American Journal of Hypertension, 1997
• D5 Irbesartan in combination with hydrochlorothiazide in mild-to-moderate hypertension
  American Journal of Hypertension, 1997
• Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
  Clinical Pharmacology & Therapeutics, 1995
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension
  Hypertension, 1995
• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
  The American Journal of Cardiology, 1995
• Dose-Response Relationships Following Oral Administration of DuP 753 to Normal Humans
  American Journal of Hypertension, 1991
• Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
  Circulation, 1991